From: Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma
Cell type
CD marker
Location
pS6
PD response
Tumor cells
CD45-; CD38+; CD138+
BMA
+++
Robust
Monocytes
CD45+; CD14+
PB, BMA
Moderate
B cells
CD45+; CD20+
-
N/A
T cells
CD45+; CD3+